Management of Hepatic Encephalopathy

Introduction to Hepatic Encephalopathy Management

Hepatic encephalopathy is a serious condition that requires prompt management, with the goal of reducing intracranial pressure (ICP) and improving cerebral perfusion pressure (CPP), as recommended by the Hepatology guidelines and supported by the American College of Surgeons and the Association of Anaesthetists 1, 2, 3

Mannitol is indicated for the treatment of severe intracranial hypertension or signs of herniation in patients with grade III/IV hepatic encephalopathy, but is not a first-line treatment for hepatic encephalopathy itself 1
The risk of cerebral edema increases dramatically with the progression of encephalopathy, with a 25-35% risk in grade III and 65-75% or higher risk in grade IV 1

For grade I-II encephalopathy, lactulose (oral or enema) is first-line therapy, and mannitol is not indicated at this stage 1
For grade III-IV encephalopathy, treatment includes transfer to ICU setting, securing airway, elevating head of bed to 30 degrees, considering ICP monitoring, and administering mannitol for ICP >20-25 mmHg despite basic measures or clinical signs of herniation 1
The goal of managing elevated ICP is to maintain ICP below 20-25 mmHg and CPP above 50-60 mmHg, as recommended by the Hepatology guidelines and supported by the American College of Surgeons and the Association of Anaesthetists 1, 2, 3

The initial dose of mannitol is 5 ml/kg IV over 15 minutes, with a maintenance dose of 1 ml/kg per hour IV, and a target serum sodium level of 150-155 mEq/L, according to the American Society of Clinical Oncology 4
The dosing and administration guidelines for mannitol are recommended as follows:

Dose	Administration	Duration of Action
0.5-1 g/kg IV	Over 15-20 minutes	2-4 hours

Hypertonic saline is effective in reducing ICP and improving cerebral perfusion pressure, with lower treatment failure rates compared to mannitol, as recommended by the American Association for the Study of Liver Diseases 1
Barbiturates can be used for refractory intracranial hypertension, requiring continuous electroencephalographic monitoring, but may cause hemodynamic instability requiring vasopressor support, as recommended by the American Stroke Association 5

Elevating the head of bed to 30 degrees is recommended to reduce ICP, as suggested by the American Society of Clinical Oncology and the American College of Critical Care Medicine 4, 1
Ensuring endotracheal intubation in patients with grade III or IV encephalopathy is crucial, as recommended by the American Thoracic Society 1
Avoiding sedation if possible in early stages of encephalopathy is recommended, as it may mask neurological deterioration, according to the American Academy of Neurology 1
Frequent neurological assessments are necessary to identify early evidence of uncal herniation, as recommended by the American Association of Neurological Surgeons 1

Maintaining a mean arterial pressure (MAP) > 80 mmHg or systolic blood pressure (SBP) > 110 mmHg is essential to ensure adequate cerebral perfusion, as recommended by the American Heart Association 5
Avoiding aggressive antihypertensive agents with venodilating effects, such as nitroprusside, is recommended, as they can worsen ICP, according to the American College of Cardiology 5
Treat hypertension with increased sedation and small boluses of labetalol, as recommended by the Anaesthesia society, with a strength of evidence level of B, according to the European Society of Intensive Care Medicine and the American College of Neurology 3, 6, 1
Treat hypotension (after correcting hypovolemia) with α-agonists, as suggested by the Anaesthesia society, with a strength of evidence level of B, according to the European Society of Intensive Care Medicine and the American College of Neurology 3, 6, 1

Ventilation management should target PaO₂ ≥ 13 kPa and PaCO₂ 4.5-5.0 kPa to maintain adequate oxygenation and prevent hypercapnia, with a strength of evidence level of A, according to the American Heart Association and the Brain Trauma Foundation 5, 2
Temporary hyperventilation to target PaCO₂ of 30-35 mmHg is recommended for patients with external brain herniation, as per the Critical Care guidelines and the Anaesthesia society, with a strength of evidence level of B, according to the European Society of Intensive Care Medicine and the American College of Neurology 7, 3, 6, 1

Maintaining platelet count > 50,000/mm³ (higher for neurosurgery) is recommended for patients with external brain herniation, as per the World Journal of Emergency Surgery guidelines, with a strength of evidence level of B, according to the European Society of Intensive Care Medicine and the American College of Neurology 8, 6, 1
Maintaining PT/aPTT < 1.5 normal control is essential for patients with external brain herniation, according to the World Journal of Emergency Surgery guidelines, with a strength of evidence level of B, according to the European Society of Intensive Care Medicine and the American College of Neurology 8, 6, 1
Consider point-of-care tests (TEG/ROTEM) to assess coagulation function, as per the World Journal of Emergency Surgery guidelines, with a strength of evidence level of B, according to the European Society of Intensive Care Medicine and the American College of Neurology 8, 6, 1

CSF drainage through an intraventricular catheter can rapidly reduce ICP if hydrocephalus is present, as recommended by the American Association of Neurological Surgeons 5
Decompressive craniectomy is the most definitive and invasive treatment for massive cerebral edema, particularly beneficial for large cerebellar infarctions/hemorrhages causing direct brain stem compression, but may result in severe residual neurological deficits in survivors of large hemispheric infarcts 5
Suboccipital craniectomy, durotomy, and duraplasty are recommended for cerebellar infarction/hemorrhage with mass effect, as per the Journal of Neurointerventional Surgery guidelines, with a strength of evidence level of B, according to the European Society of Intensive Care Medicine and the American College of Neurology 9, 6, 1